Teach-back Education Method for Wound Care Compliance
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method for teaching patients wound care, aiming to improve satisfaction and adherence to care instructions. Researchers will compare the traditional method with the "ask-tell-ask" approach, also known as the Teach-back Method. In this approach, patients discuss their wound care knowledge, receive educational information, and then repeat what they've learned to ensure understanding. The trial seeks English-speaking patients visiting a specific dermatology clinic for the first time with leg wounds healing naturally after surgery. Participants will receive guidance and follow-up calls to track their progress and experience. As an unphased trial, this study offers participants the opportunity to contribute to improving patient education methods and enhancing future care experiences.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that the ask-tell-ask education method is safe for wound care compliance?
Research has shown that the teach-back method, using the ask-tell-ask approach, is generally well-received. This method involves asking patients what they know, providing information, and then asking them to repeat it back. The educator addresses any misunderstandings.
Studies have found that this method helps patients better understand and manage their care, proving it safe and effective for patient education. No reports indicate negative effects from this method, as it is a communication tool, not a medical treatment.
In summary, current evidence supports the safety of the ask-tell-ask method for teaching patients about wound care.12345Why are researchers excited about this trial?
Researchers are excited about the ask-tell-ask education method for wound care compliance because it takes a more interactive approach to patient education compared to the standard of care. Traditional methods often involve simply providing patients with information, but ask-tell-ask encourages a two-way conversation. This method involves checking what patients already know, informing them about wound care, and then asking them to repeat the information back. This interactive process ensures that patients truly understand how to care for their wounds, which could lead to better adherence and faster healing.
What evidence suggests that the ask-tell-ask education method is effective for wound care compliance?
Research has shown that the teach-back method, referred to in this trial as the "ask-tell-ask" method, effectively helps patients understand their care. It reduces the likelihood of hospital readmissions and aids patients in better managing their health. This method involves explaining information to patients and then asking them to repeat it back to ensure comprehension. Studies have found that this technique helps patients remember what they learn and follow care instructions more closely. This approach is particularly beneficial in ensuring proper wound care.12345
Who Is on the Research Team?
Christina Wong, MD
Principal Investigator
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals getting their first Mohs Micrographic Surgery on the lower extremities at a specific outpatient clinic. It's not for those who've had this surgery before, or have mental, learning, visual disabilities, or dementia.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the teach-back method or standard of care education for wound care post-Mohs surgery
Follow-up
Participants are monitored for wound care adherence, patient experience, and complication incidence
What Are the Treatments Tested in This Trial?
Interventions
- Ask-tell-ask education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Case Comprehensive Cancer Center
Lead Sponsor